A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results for " Upadacitinib "

media.product.imagealternatetextformat.details

Upadacitinib Impurity 15

N° de SZ CAT:SZ-U005017
Número CASNA
Mol.F.C17H19F3N6O
Peso Molecular380.4
Status de FaturaCustom Synthesis

Nome Químico: (3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide compound with (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (1:1)

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: CC[C@@H](CN(C(NCC(F)(F)F)=O)C1)[C@@H]1C2=CN=C3N2C(C=CN4)=C4N=C3.CC[C@H](CN(C(NCC(F)(F)F)=O)C5)[C@H]5C6=CN=C7N6C(C=CN8)=C8N=C7

Upadacitinib Impurity 15 is chemically (3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide compound with (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide (1:1). Upadacitinib Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Upadacitinib Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Upadacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.